Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26 USD | -11.56% | -14.36% | +137.57% |
May. 21 | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
May. 09 | Q32 Bio Inc. Provides Corporate Update | CI |
Chart calendar Q32 Bio Inc.
Upcoming events on Q32 Bio Inc.
No events available
Past events on Q32 Bio Inc.
2024-05-09 06:59 am | Q1 2024 Earnings Release |
2023-11-14 04:33 pm | Q3 2023 Earnings Release |
2023-08-14 04:05 pm | Q2 2023 Earnings Release |
2023-07-27 04:30 pm | Business Update Call |
2023-06-13 | Annual General Meeting |
2023-05-24 | World Orphan Drug Congress |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 1312 |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 1497 |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 1355 |
2023-05-18 03:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract # 989 |
2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 376 |
2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 386 |
2023-05-11 04:05 pm | Q1 2023 Earnings Release |
2023-03-17 12:30 pm | ACMG Clinical Genetics Meeting |
2023-03-16 12:30 pm | ACMG Clinical Genetics Meeting |
2023-03-13 | ACMG Clinical Genetics Meeting |
2023-03-11 02:30 pm | Project Alive Hunter Syndrome Community Conference |
2023-03-09 04:05 pm | Q4 2022 Earnings Release |
2023-03-08 10:30 am | Cowen Health Care Conference - Panel |
2022-11-15 04:10 pm | Stifel Healthcare Conference |
Annual results
Fiscal Period | December | 2023 | 2024 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -53,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,5 |
Net income Million USD | Released Forecast Spread | -53,7 | -35,6 |
EPS USD | Released Forecast Spread | -7,41 | -3,85 |
Announcement Date | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -14,8 -11,9 -24.21% | -12,7 | -12,7 | -12,7 | -14,2 | -14,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1,21 -14,9 108.08% | -12,6 | -12,6 | -12,6 | -14,1 | -14,1 |
Net income Million USD | Released Forecast Spread | 1,03 -14,9 106.9% | -11,6 | -12,1 | -12,6 | -14,1 | -14,1 |
EPS USD | Released Forecast Spread | 1,03 -1,42 172.79% | -0,97 | -1,01 | -1,05 | -0,82 | -0,82 |
Announcement Date | 09/05/24 | - | - | - | - | - |
Past sector events for Q32 Bio Inc.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QTTB Stock
- Calendar Q32 Bio Inc.